Royal Bank of Canada’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Sell
84
-1,284
-94% -$10.4K ﹤0.01% 6960
2025
Q4
$15K Buy
1,368
+1,082
+378% +$16K ﹤0.01% 6215
2025
Q3
$5K Sell
286
-49
-15% -$1.24K ﹤0.01% 6714
2025
Q2
$7K Buy
+335
New +$7K ﹤0.01% 6578
2025
Q1
Sell
-113
Closed -$2K 7221
2024
Q4
$2K Buy
+113
New +$3.45K ﹤0.01% 6732
2024
Q3
Sell
-171
Closed -$2K 7430
2024
Q2
$2K Buy
+171
New +$1.85K ﹤0.01% 6755
2024
Q1
Sell
-156
Closed -$1K 7586
2023
Q4
$1K Buy
156
+155
+15,500% +$1.12K ﹤0.01% 6985
2023
Q3
$0 Hold
1
﹤0.01% 7589
2023
Q2
$0 Sell
1
-194
-99% -$2.37K ﹤0.01% 7659
2023
Q1
$3K Sell
195
-296
-60% -$4.38K ﹤0.01% 6712
2022
Q4
$6K Buy
491
+448
+1,042% +$22.1K ﹤0.01% 6698
2022
Q3
$4K Buy
43
+23
+115% +$2.63K ﹤0.01% 6830
2022
Q2
$2K Sell
20
-146
-88% -$20.7K ﹤0.01% 6997
2022
Q1
$36K Sell
166
-337
-67% -$78.8K ﹤0.01% 6292
2021
Q4
$172K Buy
503
+393
+357% +$152K ﹤0.01% 5479
2021
Q3
$40K Sell
110
-10
-8% -$3.73K ﹤0.01% 6296
2021
Q2
$46K Buy
120
+95
+380% +$35.2K ﹤0.01% 6099
2021
Q1
$13K Buy
+25
New +$12.8K ﹤0.01% 6686

Other funds holding TIL

Royal Bank of Canada's TIL Position: Q1 2026 in Review

Royal Bank of Canada reduced its Instil Bio (TIL) stake by 94% in Q1 2026, selling an estimated $10.4K and leaving 84 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6960.

Royal Bank of Canada first reported a position in TIL in Q1 2021 and has held it in 18 quarters since. The position peaked at $172K in Q4 2021. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Royal Bank of Canada held 84 shares of Instil Bio worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 1,284 Instil Bio shares in Q1 2026, an estimated $10.4K.
  • Instil Bio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6960 holding.
  • Royal Bank of Canada first reported a position in Instil Bio in Q1 2021 and has held it in 18 quarters since.
  • Royal Bank of Canada's Instil Bio position peaked at $172K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.